![Paul W. Blavin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul W. Blavin
Oprichter bij Mercy Bioanalytics, Inc.
Actieve functies van Paul W. Blavin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Mercy Bioanalytics, Inc.
![]() Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Directeur/Bestuurslid | 01-01-2018 | - |
Oprichter | 01-01-2018 | - | |
Algemeen Directeur | 01-01-2018 | 15-02-2023 |
Loopbaan van Paul W. Blavin
Eerdere bekende functies van Paul W. Blavin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PWB Value Partners LP | Oprichter | - | - |
Blavin & Co., Inc.
![]() Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Voorzitter | 01-01-1998 | - |
Chief Investment Officer | 01-01-1998 | - | |
Portefeuillebeheerder-Aandelen | 01-01-1998 | - | |
Corporate Officer/Principal | 01-01-1998 | - | |
President | 01-01-1998 | - |
Opleiding van Paul W. Blavin
Harvard Business School | Masters Business Admin |
University of Michigan | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Founder | 2 |
Chairman | 1 |
Chief Investment Officer | 1 |
Sectoraal
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Blavin & Co., Inc.
![]() Blavin & Co., Inc. Investment ManagersFinance Blavin & Co., Inc. is a hedge fund manager located in Scottsdale, Arizona. The firm was founded in 1998 by Paul W. Blavin and Michael Spalter. | Finance |
Mercy Bioanalytics, Inc.
![]() Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
PWB Value Partners LP |
- Beurs
- Insiders
- Paul W. Blavin
- Ervaring